Denise M. Bohnert - 23 Feb 2023 Form 4 Insider Report for AMEDISYS INC (AMED)

Role: Chief Compliance Officer
Signature: /s/ Jennifer R. Guckert, pursuant to a power of attorney
Issuer symbol: AMED
Transactions as of: 23 Feb 2023
Transactions value $: $0
Form type: 4
Filing time: 27 Feb 2023, 20:20:09 UTC
Previous filing: 22 Feb 2023
Next filing: 13 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMED	Common Stock	Award	$0	+1.36K	+12.57%	$0.00	12.2K	23 Feb 2023	Direct	F1
holding	AMED	Common Stock						214	23 Feb 2023	By 401(k) Plan	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMED	Stock Option (Right to Buy)	Award	$0	+2.88K		$0.00	2.88K	23 Feb 2023	Common Stock	2.88K	$91.77	Direct	F3
transaction	AMED	Restricted Stock Unit (Performance-Based Vesting)	Award	$0	+2.73K		$0.00	2.73K	23 Feb 2023	Common Stock	2.73K		Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Issuer awarded the Reporting Person 1,363 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 1/3 installments on each of February 20, 2024, 2025 and 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date.
F2	The information in this report is based on a plan statement dated as of December 31, 2022.
F3	The Stock Options are subject to time-based vesting conditions and will vest in equal, 1/3 installments on each of February 20, 2024, 2025 and 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date.
F4	The performance-based RSUs will cliff vest following a three-year performance period ending December 31, 2025 based on the Company's achievement of a pre-established performance measure for 2023, as modified by the Company's three-year total shareholder return percentile rank compared to a pre-established comparator group. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0% to 200% of the amount reported depending on the level of performance achieved.